Intra-Cellular Therapies (ITCI) Prices 10M Share Common Offering at $29.50/Sh

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. SPCX
2. HUM
3. ALHC
4. PEP
5. T
6. CVS
7. UNH
8. LMT
9. SPY
10. SBUX

Go back to Intra-Cellular Therapies (ITCI) Prices 10M Share Common Offering at $29.50/Sh

After-Hours Movers 01/06: (XERS) (CNXN) (MCHP) Higher; (ITCI) (ARE) (CRWD) Lower (more...)

January 6, 2020 5:55 PM EST

Today's After-Hours Movers

Xeris Pharmaceuticals, Inc. (Nasdaq: XERS) 20.7% HIGHER; announced positive topline results from the in-clinic stage of a Phase 2 study of its developmental ready-to-use (RTU) glucagon for the prevention of hypoglycemia during and after moderate-to-high intensity aerobic exercise in adults with Type 1 diabetes mellitus (T1D).

PC Connection Inc. (NASDAQ: CNXN) 9% HIGHER; will replace Jagged Peak Energy in the S&P SmallCap 600.

Microchip Technology Incorporated, (NASDAQ:... More

Intra-Cellular Therapies (ITCI) Announces Proposed 10M Share Common Offering

January 6, 2020 4:07 PM EST

Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) today announced that it has commenced an underwritten public offering of 10,000,000 shares of its common stock. In connection with the offering, Intra-Cellular Therapies intends to grant the underwriters a 30-day option to purchase up to an additional 15%... More